Solixant

"Soliksant" - is a modern biotechnology company with unique competence in the production of biologically active substances and drugs on the basis of microalgae.

"Soliksant" - is unique to the Russian Federation Innovation Research and Production Complex, specializes in the study and analysis of strains of microalgae and cyanobacteria, followed by the creation of pilot production of high value-added substances.

The core of the "Soliksant" technologies are advanced photobioreactors gated AGS series with a maximum capacity of up to several tens of thousands of liters. Technology "Soliksant" allow you to create a biotech chain for industrial cultivation of microalgae biomass with the subsequent release of a wide range of materials with high thermal value.

The main mission we see improvement in the quality and life expectancy, due to the introduction (the commercialization and promotion of the market), green technologies, which are based on the use of microalgae.

Microalgae - the fastest growing biomass on the planet, with a diversity of species in excess of hundreds of thousands of species. In addition, seaweed is not a whimsical substrate and water quality. These organisms are some of the most promising producers (natural biofactories) biologically active substances - polyunsaturated fatty acids, carotenoids, vitamins and amino acids. In addition, microalgae exhibit extremely high plasticity, altering metabolism, depending on the physiological state; ie the profile of the synthesized compounds easily switched due to various forms of stress, such as a lack of nitrogen.

One of the main tasks we consider updating developments of Soviet science. In the USSR, a unique collection of microalgae has been collected, which has several thousand species, most of which have not been studied. As a result, the overwhelming majority of biotechnological potential of these microorganisms have not yet been activated.

Технологии

The aim of the project is to study a broad panel of cultures of microalgae and cyanobacteria as producers of commercially attractive new generation of antibiotics. For mass screening of producers of new antibiotics, the company Solix BioSystems uses iChip, adapted technology for phototrophic microorganisms.

As used in the project approach is to find new producers of antibiotics includes the use of modified iChip technology, which was previously allowed to find the first in the last 30 years, a new type of antibiotics from soil microflora, the use of their own collections fotototrofnyh microorganisms and access to the depositary of the leading scientific research institute of the Russian Federation, the use of advanced Solix Technologies BioSystems Inc., the capacity of microalgae biomass in laboratory and pilot scale.

"Soliksant" has an extensive collection of high-yield strains of microalgae and is the only company in Russia, capable of producing high-quality 100% natural supplements for aquaculture, based on omega-3 fatty acids and antioxidants from microalgae. This is ensured by the presence of Russia's largest facilities for the cultivation of microalgae in photobioreactors latest generation.

Products are manufactured without the use of solvents from 100% natural raw material (microalgae) and does not contain GMOs and artificial additives, which guarantees safety and environmental friendliness of the product. Due to its characteristics, this product has a wide range of applications in aquaculture, poultry farming, functional food, bioadditives.

solixant
Partners

The company "Soliksant" I2BF is a portfolio company and a member of the technological "Bioenergy" platform brings together the leading Russian organization in the field of biotechnology, as well as participants in the innovation center Skolkovo and Rusnano portfolio company. The company also collaborates with many research institutions.

Press
ТАСС:
Препарат из водорослей, найденных советскими учеными, представят на «Открытых инновациях»
Открыть новость
Мегамозг:
Советы основателя. Денис Кузьмин, генеральный директор «Соликсант»
Открыть новость
Роснано:
В Москве при поддержке «Соликсант» наградили лауреатов премии имени Р. Б. Хесина в области биологии
Открыть новость
Роснано:
РОСНАНО совместно с американским партнером инвестирует в биотехнологии
Открыть новость
Сколково:
Фонд «Сколково» подвел первые итоги развития биотехнологий в сельском хозяйстве
Открыть новость
Сколково:
Финал отраслевого конкурса проектов «АгроБиотехнологии 2015»
Открыть новость
Гиктаймс:
Ответы гендиректора «Соликсант» на вопросы пользователей Geektimes
Открыть новость
Гиктаймс:
Ответы гендиректора «Соликсант» на вопросы пользов
Открыть новость
Гиктаймс:
Препарат из водорослей, найденных советскими учеными, представят на «Открытых инновациях» 12342143 4545 324124124123123 8 324
Открыть новость